Healthcare
Health
Information Technology

Quest Diagnostics

$88.45
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.79 (-0.89%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell DGX and other stocks, options, ETFs, and crypto commission-free!

About

Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. Read More The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.

Employees
46,000
Headquarters
Secaucus, New Jersey
Founded
1969
Market Cap
12.05B
Price-Earnings Ratio
16.70
Dividend Yield
2.44
Average Volume
1.13M
High Today
$89.09
Low Today
$87.59
Open Price
$89.09
Volume
605.62K
52 Week High
$116.49
52 Week Low
$78.95

Collections

Healthcare
Health
Information Technology
Technology
Medical
Software Service
US
North America

News

Simply Wall St8h

What You Need To Know About Quest Diagnostics Incorporated’s (NYSE:DGX) Cash Situation

Two important questions to ask before you buy Quest Diagnostics Incorporated (NYSE:DGX) is, how it makes money and how it spends its cash.

7
Yahoo Finance9h

Quest Diagnostics Grows on New Pacts Amid Reimbursement Issue

On Mar 22, we issued an updated research report on Quest Diagnostics, Inc. DGX. As a part of its two-point strategy, Quest Diagnostics has been focusing on areas with high potential. However, the reimbursement scenario remains a major cause of concern for thisZacks Rank #3 (Hold) company. Quest Diagnostics is currently focusing on diagnostic information services and disciplined capital deployment. Meanwhile, the company’s acquisitions and collaborations with hospitals and integrated delivery networks act a...

4
TradingNewsNowMar 19

Valuation Today: Quest Diagnostics (NYSE: DGX)

Quest Diagnostics trades as part of the medical diagnostics and research industry and healthcare sector. The company CEO is Stephen H. Rusckowski. Quest Diagnostics Inc provides diagnostic testing, information, and services, providing insights that enable patients and physicians to make healthcare decisions. It provides diagnostics for insurers and healthcare information technology businesses. Previous Intraday Trading Performance: The DGX stock showed a previous change of 0.28% with an open at 87.89 and ...

51

Earnings

$1.36
$1.49
$1.63
$1.76
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Available Apr 23, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.